News in the Life Sciences Industry | |
Results 321 - 340 out of 448 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 » |
IO Biotech Announces Late-Breaking Oral Presentation of Phase 2 Clinical Melanoma Data Including Complete Response (CR) Rate of 45 Percent |
COPENHAGEN, Denmark, Sept. 17, 2020 /PRNewswire/ -- IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune-modulating anti-cancer therapies based on its proprietary T-win® technology, today announced a late-breaking, oral presentation of best-in-class efficacy data in... Read more ›› |
By: PR Newswire Association LLC. - 18 Sep 2020 |
InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer |
Read more ›› |
By: GlobenewsWire - 17 Sep 2020 |
Related companies: InflaRx N.V. |
Abbott Introduces Libre Sense Glucose Sport Biosensor in Europe, World's First Glucose Biosensor Designed for Athletes |
ABBOTT PARK, Ill., Sept. 17, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) is introducing the world's first glucose sport biosensor,(i) Libre Sense Glucose Sport Biosensor, which is designed for athletes to continuously measure glucose to better understand the correlation between their glucose levels... Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
Related companies: Abbott GmbH & Co. KG | Abbott Rapid Diagnostics Germany GmbH | Abbott Medical GmbH |
HARTMANN launches Mission: Infection Prevention - how prevention is contagious |
HEIDENHEIM, Germany, Sept. 17, 2020 /PRNewswire/ -- Together with the "World Day for Patient Safety" of the World Health Organization (WHO), today HARTMANN is launching its initiative to reduce the risk of healthcare-related infection - Mission: Infection Prevention (M: IP). The company is... Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
Related companies: Paul Hartmann AG |
Four 20 Pharma and Northern Green Canada Complete Successful Shipment of Medical Cannabis |
Supply Agreement will continue into 2021 Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021 |
Read more ›› |
By: GlobenewsWire - 17 Sep 2020 |
Related companies: BioNTech SE |
MYR Pharmaceuticals launches HEPCLUDEX® in Germany, France and Austria |
BAD HOMBURG, Germany, Sept. 17, 2020 /PRNewswire/ -- MYR Pharmaceuticals, a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D, is pleased to announce that HEPCLUDEX(®) (bulevirtide) has successfully launched... Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
Related companies: MYR Pharmaceuticals |
Santen and U.S. Ophthalmic Company Eyevance Enter into Share Purchase Agreement |
OSAKA, Japan and FORT WORTH, Texas, Sept. 16, 2020 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (hereinafter "Santen") and Eyevance Holdings LLC announced that Santen Holdings U.S. Inc., a wholly-owned subsidiary of Santen, and Eyevance Holdings LLC entered into a share purchase agreement... Read more ›› |
By: PR Newswire Association LLC. - 17 Sep 2020 |
CENTOGENE to Report First Half 2020 Financial Results on September 23, 2020 |
Read more ›› |
By: GlobenewsWire - 16 Sep 2020 |
Related companies: Centogene N.V. |
"The Most Innovative Product" awarded to novel dietary supplement spermidineLIFE® |
MUNICH, VIENNA and DENVER, Sept. 16, 2020 /PRNewswire/ -- TLL The Longevity Labs GmbH (Longevity Labs+), an Austrian-based life sciences company, and its wholly-owned, US subsidiary, Longevity Labs Inc., are proud to announce their award for "The Most Innovative OTC-Product" at the German 2020... Read more ›› |
By: PR Newswire Association LLC. - 16 Sep 2020 |
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162 |
Read more ›› |
By: GlobenewsWire - 15 Sep 2020 |
Related companies: BioNTech SE |
Immatics Appoints Biotech Executive Eliot Forster to Board of Directors |
Read more ›› |
By: GlobenewsWire - 15 Sep 2020 |
Related companies: Immatics Biotechnologies GmbH |
CIRT-EU Registry for SIR-Spheres® Therapy presented at CIRSE 2020 Summit |
WOBURN, Mass., Sept. 15, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer... Read more ›› |
By: PR Newswire Association LLC. - 15 Sep 2020 |
Related companies: Sirtex Medical Europe GmbH |
Dell, HP, Lenovo and Acer to Announce New Eyesafe Products at the Blue Light Summit 2020 Presented by UnitedHealthcare, Eyesafe and TÜV Rheinland |
SHANGHAI and BERLIN and MINNEAPOLIS, Sept. 15, 2020 /PRNewswire/ -- Eyesafe, UnitedHealthcare Vision and TÜV Rheinland Group today announced the dates and registration details as well as the initial lineup of companies and thought leaders participating in the Read more ›› |
By: PR Newswire Association LLC. - 15 Sep 2020 |
Related companies: TÜV Rheinland AG |
InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia |
Read more ›› |
By: GlobenewsWire - 14 Sep 2020 |
Related companies: InflaRx N.V. |
NASIR-HCC: Phase 2 study of Sirtex Medical SIR-Spheres(R) Y-90 resin microspheres followed by Nivolumab therapy demonstrates favorable safety and tolerability profile at ILCA 2020 |
WOBURN, Massachusetts, Sept. 14, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapy, SIR-Spheres® Y-90 resin microspheres, is pleased to report that positive trial data from the NASIR-HCC Study was reported by Professor Bruno Sangro at the... Read more ›› |
By: PR Newswire Association LLC. - 14 Sep 2020 |
Related companies: Sirtex Medical Europe GmbH |
NASIR-HCC: Phase 2 study of Sirtex Medical SIR-Spheres® Y-90 resin microspheres followed by Nivolumab therapy demonstrates favorable safety and tolerability profile at ILCA 2020 |
WOBURN, Mass., Sept. 14, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapy, SIR-Spheres® Y-90 resin microspheres, is pleased to report that positive trial data from the NASIR-HCC Study was reported by Professor Bruno Sangro at the International... Read more ›› |
By: PR Newswire Association LLC. - 14 Sep 2020 |
Related companies: Sirtex Medical Europe GmbH |
Novo Nordisk A/S – Share repurchase programme |
Read more ›› |
By: GlobenewsWire - 14 Sep 2020 |
Accord Healthcare Enters Exclusive Distribution Agreement with Molteni Farmaceutici for First Buprenorphine Implant Approved in Europe |
This press release is intended for trade and medical press journalists only. This press release is NOT intended for consumer press journalists. Read more ›› |
By: PR Newswire Association LLC. - 14 Sep 2020 |
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial |
Read more ›› |
By: GlobenewsWire - 12 Sep 2020 |
Related companies: BioNTech SE |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 » |
Upcoming Life Sciences Events
- January 2021
- NutrEvent
- AgeingFIT
- February 2021
- Swiss Nordic Bio 2021